Premium Insights - Medical Imaging
Read our Analysts’ insights and expert opinions on the latest healthcare technology industry developments and market trends. Signify Research provides both free insights and premium insights which are only available to subscribers of "Signify Premium Insights".
Click on the premium insights link below to filter for just the premium content.
Signify Premium Insight: Vendor Financials Round-up – The Health of the Imaging Sector Q1 2023
Signify Premium Insights – Medical Imaging Subscription Required
May 30th 2023 – Headwinds still blow, but many of the most volatile factors impacting the prospects of medical imaging vendors abated in 2023’s first quarter. There are, however, still challenges looming on the horizon.
Signify Premium Insight: Clarius Encourages its Customers to Speak Up
Signify Premium Insights – Medical Imaging Subscription Required
May 25th 2023 – Clarius, like other handheld ultrasound vendors, is focused on generating revenues through the sale of affordable devices. Can adding features like voice control help it achieve this aim?
Signify Premium Insight: Ultromics’ AI Heart Breakthrough
Signify Premium Insights – Medical Imaging Subscription Required
May 23rd 2023 – Ultromics has been granted Breakthrough Device Status for its artificial intelligence platform for cardiac amyloidosis detection. It could herald a lucrative move for the vendor, but it could also have a wider impact.
Signify Premium Insight: United Imaging: Self-Awareness and Strategic Dilemmas
Signify Premium Insights – Medical Imaging Subscription Required
May 18th 2023 – United Imaging has released its first annual report since listing as a public company. The vendor enjoyed solid growth, but the report also revealed difficult strategic decisions.
Signify Premium Insight: Philips Acquires the Means to Make a Statement
Signify Premium Insights – Medical Imaging Subscription Required
May 16th 2023 – Philips has acquired ultrasound AI vendor DiA Imaging Analysis. The move makes clear the Dutch vendor’s priorities, while DiA is also set to gain.